Mohsen Amini Selected Research

Blood Glucose (Blood Sugar)

1/2018	Synthesis and characterization of a novel peptide-grafted Cs and evaluation of its nanoparticles for the oral delivery of insulin, in vitro, and in vivo study.
5/2013	Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients.
11/2012	Predictive factors for ultrasonographic grading of nonalcoholic Fatty liver disease.
9/2012	Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohsen Amini Research Topics

Disease

48	Neoplasms (Cancer) 01/2024 - 08/2009
14	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2009
7	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 06/2010
7	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015 - 06/2010
6	Edema (Dropsy) 01/2014 - 11/2003
5	Colonic Neoplasms (Colon Cancer) 06/2019 - 01/2014
5	Infections 12/2015 - 07/2010
4	Necrosis 11/2020 - 12/2018
4	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 01/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2013
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2015 - 06/2013
4	Pheochromocytoma 05/2011 - 06/2010
3	Diabetes Mellitus 01/2019 - 09/2012
2	Prostatic Neoplasms (Prostate Cancer) 04/2021 - 01/2017
2	Hyperglycemia 01/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2020
2	Body Weight (Weight, Body) 01/2020 - 11/2012
2	Glioma (Gliomas) 01/2020 - 01/2013
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 02/2017 - 03/2014
2	Seizures (Absence Seizure) 01/2017 - 09/2012
2	Wounds and Injuries (Trauma) 05/2016 - 01/2016
2	Dyspepsia (Indigestion) 12/2015 - 04/2012
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2015 - 07/2014
2	Hemorrhage 10/2014 - 09/2012
2	Inflammation (Inflammations) 01/2014 - 11/2003
2	Hypertension (High Blood Pressure) 07/2013 - 05/2013
2	Chronic Renal Insufficiency 07/2013 - 09/2012
2	Dyslipidemias (Dyslipidemia) 05/2013 - 09/2012
2	Hepatitis B 05/2013 - 09/2012
2	Non-alcoholic Fatty Liver Disease 11/2012 - 09/2012

Drug/Important Bio-Agent (IBA)

9	Docetaxel (Taxotere)FDA Link 04/2021 - 08/2009
8	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 03/2014
6	MicellesIBA 01/2024 - 10/2013
6	Liposomes (Liposome)IBA 06/2019 - 10/2013
6	ChitosanIBA 12/2018 - 11/2013
6	CarrageenanIBA 01/2014 - 11/2003
5	Caspase 3 (Caspase-3)IBA 01/2020 - 06/2010
5	Fluorouracil (Carac)FDA LinkGeneric 06/2019 - 02/2018
5	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016 - 11/2003
5	Celecoxib (Celebrex)FDA Link 03/2014 - 11/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 03/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
4	Hyaluronic Acid (Hyaluronan)IBA 08/2020 - 06/2014
4	Peptides (Polypeptides)IBA 01/2020 - 11/2017
4	Insulin (Novolin)FDA Link 01/2020 - 11/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2019 - 06/2010
4	Blood Glucose (Blood Sugar)IBA 01/2018 - 09/2012
4	AlbuminsIBA 08/2016 - 08/2009
4	Human Serum Albumin FDA LinkGeneric 01/2016 - 07/2013
4	Neuroprotective AgentsIBA 12/2013 - 06/2010
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 04/2021 - 01/2011
3	Annexin A5IBA 11/2020 - 01/2019
3	Gemcitabine FDA Link 11/2020 - 07/2014
3	MicroRNAs (MicroRNA)IBA 08/2020 - 11/2015
3	TubulinIBA 01/2020 - 01/2019
3	indibulinIBA 01/2020 - 01/2019
3	Cytochromes c (Cytochrome c)IBA 06/2019 - 09/2018
3	Antineoplastic Agents (Antineoplastics)IBA 06/2019 - 01/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 08/2016
2	polycaprolactoneIBA 01/2024 - 11/2017
2	Tubulin ModulatorsIBA 01/2022 - 01/2019
2	AntigensIBA 04/2021 - 01/2011
2	LigandsIBA 04/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 04/2021 - 08/2007
2	EnzymesIBA 01/2021 - 01/2020
2	GlucosidasesIBA 01/2021 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 12/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 11/2020 - 11/2013
2	ButyrylcholinesteraseIBA 02/2020 - 07/2018
2	Radioisotopes (Radionuclides)IBA 01/2020 - 01/2020
2	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2020 - 01/2020
2	AntioxidantsIBA 01/2020 - 01/2014
2	cabazitaxel FDA Link 11/2017 - 01/2017
2	biotin receptorIBA 05/2017 - 01/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2017 - 01/2014
2	Biotin (Vitamin H)FDA Link 05/2017 - 01/2016
2	poly(ethylene glycol)-folateIBA 02/2017 - 03/2014
2	Pentylenetetrazole (Metrazol)IBA 01/2017 - 09/2012
2	Sirolimus (Rapamycin)FDA Link 08/2016 - 10/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2016 - 01/2016
2	HydrogelsIBA 05/2016 - 01/2016
2	PolymersIBA 05/2016 - 01/2016
2	OxadiazolesIBA 01/2016 - 01/2016
2	UreaseIBA 12/2015 - 07/2010
2	IronIBA 11/2015 - 12/2013
2	Deferasirox FDA Link 11/2015 - 12/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2014 - 01/2014
2	Drug CarriersIBA 03/2014 - 07/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2013 - 09/2012
2	EstersIBA 01/2013 - 01/2008
2	AcidsIBA 04/2012 - 08/2007
2	2-ethoxy-4,5-diphenyl-1,3-oxazine-6-oneIBA 05/2011 - 05/2011
2	LipopolysaccharidesIBA 05/2011 - 12/2010
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2010 - 06/2010

Therapy/Procedure

18	Therapeutics 03/2024 - 12/2010
4	Drug Therapy (Chemotherapy) 11/2020 - 05/2017
3	Liver Transplantation 11/2014 - 06/2013
2	Topical Administration 05/2016 - 01/2016
2	Traditional Medicine (Folk Remedies) 01/2014 - 07/2013